We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $163M
1-Year Est. Return 240.43%
This Fund
S&P 500
This Quarter Est. Return
-17.01%
1 Year Est. Return
+240.43%
3 Year Est. Return
+409.28%
5 Year Est. Return
+142.09%
10 Year Est. Return
+4,071.98%
AUM
$174M
AUM Growth
+$95.5M
Cap. Flow
+$139M
Cap. Flow %
79.75%
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$94.5M
2
OCUL icon
Ocular Therapeutix
OCUL
+$44.5M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 97.98%
2 Miscellaneous 2.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GKOS icon
1
Glaukos
GKOS
$10.1B
$76M 43.59%
+3,142,217
New +$94.5M
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
$37.5M 21.49%
407,416
– –
OCUL icon
3
Ocular Therapeutix
OCUL
$2.3B
$31.1M 17.86%
+2,215,384
New +$44.5M
FPRX
4
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$16.8M 9.64%
1,092,152
– –
AKAO
5
DELISTED
Achaogen Inc
AKAO
$7.38M 4.23%
1,281,152
– –
BITI
6
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
$3.52M 2.02%
268,672
– –
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
$2.03M 1.17%
1,048,601
– –

Similar funds

TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GF
Gimbal Financial Carmel, Indiana $163M AUM
ACM
Arrington Capital Management Miami, Florida $163M AUM
KFS
Krane Financial Solutions Calabasas, California $162M AUM
VB
Value Base Tel Aviv, Israel $162M AUM 2.31% 1-Year Est. Return
RWA
Reicon Wealth Advisors Atlanta, Georgia $162M AUM
CCM
Candelo Capital Management New York $162M AUM 112.87% 1-Year Est. Return
GCM
Generation Capital Management Pittsford, New York $163M AUM 42.22% 1-Year Est. Return

Versant Venture Management's Q3 2015 Portfolio in Review

As of Q3 2015, Versant Venture Management held 7 positions worth $174M, up 121% from $78.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Versant Venture Management deployed $139M of net new capital in Q3 2015, opening 2 new positions. Its largest new stake was Glaukos: 3,142,217 shares worth $76M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 93% a quarter earlier, followed by Miscellaneous.

  • Versant Venture Management's largest Q3 2015 buy was Glaukos: 3,142,217 shares worth $76M.
  • Versant Venture Management's ten largest holdings make up 100% of its $174M portfolio in Q3 2015.
  • Versant Venture Management opened 2 new positions and closed 0 in Q3 2015.
  • Versant Venture Management's portfolio value rose 121% quarter-over-quarter to $174M.

Based on Versant Venture Management's 13F filing for Q3 2015, filed 28 Oct 2015.